|Articles|August 7, 2019

Cigarette Smoke Boosts Virulence Potential of S aureus, Making It More Resistant

Investigators exposed 6 genetically distinct, clinically relevant methicillin-resistant S aureus isolates to cigarette smoke to analyze how this contact altered specific virulence phenotypes.

Cigarette smoke may affect the virulence of certain bacterial strains of Staphylococcus aureus, making the pathogen more resistant to antibiotics, according to a new study from investigators at the University of Bath in the United Kingdom.

The research team sought to evaluate the effects of cigarette smoke on the bacteria that inhabit the nasopharynx and/or upper respiratory tract—areas directly exposed to cigarette smoke—given its known association with immune dysregulation and increased risk of infectious disease.

Investigators exposed 6 genetically distinct, clinically relevant methicillin-resistant S aureus (MRSA) isolates to cigarette smoke to analyze how this contact altered specific virulence phenotypes known to be important in animal models of infection.

The findings, published in Scientific Reports, were quite surprising, according to Maisem Laabei, PhD, a lecturer in microbiology in the Department of Biology and Biochemistry at the University of Bath, and co-author on the study.

“Our results indicated that cigarette smoke increased biofilm formation, invasion, and persistence within alveolar epithelial cells and reduced toxin production. Surprisingly, cigarette smoke exposure also significantly accelerated small colony variant (SCV) formation,” he said. “SCVs are resistant to a number of antibiotics and are associated with chronic infections as they are highly invasive and can persist within human cells making them very difficult to treat. Taken together, our results suggest that MRSA exposed to cigarette smoke redirects its virulence potential to one associated with persistent, difficult-to-treat infections.”

Also, interestingly, the team “observed that S aureus community-acquired (CA-) MRSA strains (JKD6159, MW2 and JE2 [USA300]) are better able to survive and replicate within cigarette smoke-[tryptic soy broth] than health care-acquired (HA) MRSA (EMRSA-15; CA/HA MRSA strain, TW20 and MRSA252) and lab strains (SH1000 and Newman).”

Upon further investigation into the observation that cigarette smoke accelerated SCV formation, the research team found that cigarette smoke exposure also enhanced the frequency of mutations in S aureus, according to Laabei.

“We then showed that a specific DNA repair pathway was involved, and that cigarette smoke resulted in DNA damage, triggering this pathway which resulted in more mutations and accelerated SCV formation,” he said. “Our results indicate that cigarette smoke exposure can significantly alter many aspects of S aureus physiology and virulence. We now need to investigate how this occurs with low grade exposure over longer time periods, in essence trying to mimic a more in vivo environment.”


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.